- Home
- LTRN vs AUST Comparison
LTRN vs AUST Comparison
Compare LTRN & AUST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LTRN | AUST |
|---|---|---|
| Founded | 2013 | 2020 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.2M | 19.2M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LTRN | AUST |
|---|---|---|
| Price | $2.18 | $1.36 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 72.6K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.65 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.11 | $1.16 |
| 52 Week High | $5.74 | $3.92 |
Technical Indicators
Market Signals| Indicator | LTRN | AUST |
|---|---|---|
| Relative Strength Index (RSI) | 48.38 | 37.00 |
| Support Level | $1.11 | $1.24 |
| Resistance Level | $2.41 | $1.59 |
| Average True Range (ATR) | 0.30 | 0.09 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 40.21 | 13.24 |
Price Performance
Historical ComparisonAbout LTRN Lantern Pharma Inc.
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
About AUST Austin Gold Corp.
Austin Gold Corp is focused on the acquisition, exploration, and evaluation of mineral resource properties in the western United States of America (USA). The exploration and development of mineral projects is considered the Company's single business segment. Its projects include Kelly Creek, Lone Mountain, Stockade Mountain, Fourmile Basin, and Miller.